Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination.

Fawzy MN, Abdelaziz AM, Shokr MM, Fathy MK

Neuropharmacology. 2026 Oct 01; 297:111042. PMID: 42208757. Abstract